Effects of Dan-Lou Tablet for Coronary Heart Disease Stable Angina Pectoris with Intermingled Phlegm and Blood Stasis Pattern: A Randomized, Double-blinded, Parallel Placebo controlled Trial
- Conditions
- Coronary heart disease stable angina pectoris
- Registration Number
- ITMCTR1900002839
- Lead Sponsor
- Guang'anmen Hospital,Chinese Academy of Traditiona Chinese medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Conform to the diagnosis of coronary heart disease stable angina pectoris with intermingled phlegm and blood stasis Pattern;
2. Between the ages of 30 and 75 years;
3. Volunteer for this event and sign an informed consent form.
1. Unstable angina pectoris and acute myocardial infarction; other congenital heart disease, valvular disease, severe neurosis caused by chest pain; heart function of grade III or IV; chest pain caused by arrhythmia;
2. Acute stage of cerebral infarction;
3. Complicated with heart, brain, liver, kidney, hematopoietic system and other serious primary diseases abnormal renal function;
4. Acute infection within the last two weeks;
5. Patients with other serious diseases that require treatment;
6. Mental disorders or mental retardation that cannot complete the questionnaire;
7. Pregnant and lactating women;
8. Tendency to bleed, abnormal of DIC or INR, low platelet;
9. Patients who did not participate in other clinical trials within 1 month;
10. Allergic constitution or allergic to test drug ingredient.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of angina pectoris attack;Outcome of safety;
- Secondary Outcome Measures
Name Time Method Duration of angina pectoris attack;Efficacy evaluation criteria for coronary heart disease angina pectoris with traditional chinese medicine treatment;Change of blood lipid;Efficacy of electrocardiograph;Reduction rate of rescue drug ;